Results 181 to 190 of about 140,561 (343)
The changing face of hepatic resection [PDF]
Iwatsuki, S, Sheahan, DG, Starzl, TE
core +1 more source
Hypervision Proton Surgery: The Future Direction of Proton Therapy
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley +1 more source
Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy [PDF]
Amr Elrabat +3 more
openalex +1 more source
Spontaneous Total Necrosis of Hepatocellular Carcinoma
Na Ra Kim +9 more
openaire +1 more source
The Endothelial CXCR Family in Vascular Health and Disease
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu +4 more
wiley +1 more source
Pathophysiology of ascites formation in cirrhosis of the liver [PDF]
Gerbes, Alexander L.
core +1 more source
Abstract No. 154 Using Post–Yttrium-90 PET/CT To Identify Tumors More Likely to have Complete Pathologic Necrosis After Radiation Segmentectomy for Hepatocellular Carcinoma [PDF]
M. Tahir +9 more
openalex +1 more source
N6‐Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential
ABSTRACT Accumulating evidence highlights the critical role of epigenetic modifications, particularly N6‐methyladenosine (m6A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m6A is dynamically regulated by multicomponent m6A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m6A‐binding ...
Yingfen Chen +6 more
wiley +1 more source

